Search

Acquired Brain Injury (ABI) is the leading cause of death and disability in children, yet educators report a lack of knowledge about ABI and supporting students with ABI. With no formal learning about ABI, education professionals may turn to the internet for information. To find online resources about supporting students with ABI, in any format, available freely and publicly, aimed toward elementary educators and that could be applied in a Canadian context. We performed an environmental scan using keyword Google searches, key websites, and expert recommendations. The search was performed twice: 2018 and 2021. 96 resources were included after screening. The resources were published by organizations in the United States (n = 57), Canada (n = 19), United Kingdom (n = 16), Australia (n = 3) and New Zealand (n = 1). Traumatic brain injury and concussion were the most commonly addressed type of ABI, and Short Fact/Information sheets were the most common resource format. Between 2018 and 2021, 13 previously included resource links were no longer accessible. This scan suggests that there are many online resources available to educators in a variety of formats, and that information online can be transient. Future studies should evaluate the accuracy and quality of the resources available. [ABSTRACT FROM AUTHOR]

Rural, cold climate communities, such as those in coastal and northern Newfoundland and Labrador, face documented challenges pertaining to financial and infrastructure constraints and changing personnel considerations. Fire service delivery must adapt to these realities. The aim of this paper is to understand the scope of the scholarly and grey literature addressing challenges and solutions for fire service delivery and firefighting in rural and cold climate contexts, particularly as they pertain to Newfoundland and Labrador, Canada. The review was conducted using an academic search engine, topic-specific search engines, grey literature databases, and a review of relevant websites to produce information sources. Peerreviewed articles, professional reports, theses and dissertations, and other article types indicated several challenges and solutions. The challenges identified were represented in scholarly and grey literature. These included challenges related to resources, the environment, firefighting tasks, and community. Likewise, solutions centred around resources, firefighting tasks, and community were represented in both scholarly and grey literature. Specific identification of future research needs was limited in the research reviewed. Further investigation and evaluation of the efficacy of solutions for specific cold climate, rural regions are advised. [ABSTRACT FROM AUTHOR]

BACKGROUND: Companies often defending their products when there are concerns about their safety and/or effectiveness. OBJECTIVE: This study looks at drugs removed from the Canadian market from 1990 onward and examines how companies responded. METHODS: This descriptive analysis used a previously published article and a hand search of a Government of Canada website to generate a list of drugs withdrawn from Canada from 1990 onwards. For each product the following information was extracted: brand name, generic name, company, date of withdrawal and evidence base for withdrawal. Google and Factiva searches were used to identify sources containing statements from the company about the withdrawal. Statements were independently graded by two people into the following categories: company agrees with the withdrawal; drug could be used safely with certain precautions; company may reintroduce the drug; company disagrees with the withdrawal. Searches were carried out between September 15–20, 2020. RESULTS: There were 22 drugs for which there were company statements. In 10 statements, the companies disagreed with the decision to withdraw the drug and in 7 they agreed with the decision. In the other 5 cases they felt that the drug could have been kept on the market with restrictions (2 cases) or they might reintroduce the drug (3 cases). The level of evidence for the withdrawal did not seem to influence the companies' position. CONCLUSION: In 15 out of 22 cases, the company either disagreed with the decision to withdraw the drug or felt that the drug should continue to be available to Canadian patients. [ABSTRACT FROM AUTHOR]